Vabysmo (faricimab-svo)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vabysmo (faricimab-svo), covering 2022-05-04 to 2022-05-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) [Phase 3]